Jean-Jacques Kiladjian/LinkedIn
Apr 12, 2026, 14:18
Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared on LinkedIn:
“Thanks to the Malaysian Society of Haematology for the invitation to participate in the ‘Highlights of ASH’ in Asia-Pacific 2026.
Delighted to discuss the advances of interferon treatment in MPNs with Winnie Teo from National University of Singapore National University Cancer Institute, Singapore and Chew Lee Ping from Borneo.”
More posts featuring Jean Jacques Kiladjian on Hemostasis Today.
-
May 28, 2026, 13:42Claudio Laudani: Balancing Ischemic and Bleeding Risk in AF with Coronary Disease
-
May 28, 2026, 13:30When it Comes to Stroke Care, Quality Matters – Duke Health
-
May 28, 2026, 13:29Natalie Johnson: Transforming PE Care Through Endovascular Innovation
-
May 28, 2026, 13:16Francisco Chacón-Lozsán: Anticoagulation Strategies for Complex ICU Patients
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early